Citation Impact
Citing Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
2005 Standout
A Pilot Study of Consolidative Immunotherapy in Patients with High-Risk Pediatric Sarcomas
2008
LncRNA HOXA11-AS Promotes Proliferation and Invasion of Gastric Cancer by Scaffolding the Chromatin Modification Factors PRC2, LSD1, and DNMT1
2016 Standout
The MYCN Enigma: Significance of MYCN Expression in Neuroblastoma
2006
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Dendritic Cell Targeting of Survivin Protein in a Xenogeneic Form Elicits Strong CD4+ T Cell Immunity to Mouse Survivin
2006 StandoutNobel
Sarcoma and Skin Radiation Oncology
2006
Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification
2007
Basal cell carcinomas: attack of the hedgehog
2008 Standout
Neuroblastomas with chromosome 11q loss and single copy MYCN comprise a biologically distinct group of tumours with adverse prognosis
2001
The epidemiology of bone cancer in 0 - 39 year olds in northern England, 1981 - 2002
2010
A systematic review of worldwide incidence of nonmelanoma skin cancer
2012 Standout
Soft Tissue Leiomyosarcomas and Malignant Gastrointestinal Stromal Tumors: Differences in Clinical Outcome and Expression of Multidrug Resistance Proteins
2000
Trends in the incidence of nonmelanoma skin cancer in Denmark 1978–2007: Rapid incidence increase among young Danish women
2010
Detailed deletion mapping of chromosome band 14q32 in human neuroblastoma defines a 1.1-Mb region of common allelic loss
2000
Incidence of Basal Cell and Squamous Cell Carcinomas in a Population Younger Than 40 Years
2005
Comparative genomic hybridization (CGH) analysis of stage 4 neuroblastoma reveals high frequency of 11q deletion in tumors lackingMYCN amplification
2001
Osteosarcoma incidence and survival rates from 1973 to 2004
2009 Standout
The biologic basis for neuroblastoma heterogeneity and risk stratification
2005
Molecular imaging in drug development
2008 Standout
Survival of children with bone sarcoma in Europe since 1978
2001
The multitude and diversity of environmental carcinogens
2007 StandoutNobel
MYC on the Path to Cancer
2012 Standout
Targeting programmed cell death pathways with experimental therapeutics: opportunities in high-risk neuroblastoma
2005
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
2012 Standout
A systematic review of molecular and biological markers in tumours of the Ewing's sarcoma family
2002
The effects on human health from stratospheric ozone depletion and its interactions with climate change
2007
Cytogenetics in acute leukemia
2003
Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high‐risk sarcomas
2006
Late Recurrence in Pediatric Cancer: A Report From the Childhood Cancer Survivor Study
2009
Surgical options for children with osteosarcoma
2005
Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal Tumor
2001 Standout
Cancer Metastasis: Building a Framework
2006 Standout
WNT signalling pathways as therapeutic targets in cancer
2012 Standout
Molecular characterisation of soft tissue tumours: a gene expression study
2002 Standout
Cancer drug resistance: an evolving paradigm
2013 Standout
Long noncoding RNAs: a potential novel class of cancer biomarkers
2015
Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing
2011 Standout
Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial
2005
Nutrition and physical activity guidelines for cancer survivors
2012 Standout
Lifestyle-related factors and environmental agents causing cancer: An overview
2007 StandoutNobel
Neuroblastoma: biological insights into a clinical enigma
2003 Standout
Abnormal constitutional karyotypes in patients with neuroblastoma: a report of four new cases and review of 47 others in the literature
2003
Notch signaling in neuroblastoma
2004
Screening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in UBE4B/UFD2
2003
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
Renal late effects in patients treated for cancer in childhood: A report from the Children's Oncology Group
2008
Soft-Tissue Sarcomas in Adults
2005 Standout
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial
2006 Standout
The Transcriptome of the Intraerythrocytic Developmental Cycle of Plasmodium falciparum
2003 Standout
The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/β-catenin pathway
2009
Osteosarcoma
2010 Standout
Two-Stage Revision for Infected Endoprostheses Used in Tumor Surgery
2002
Oncogenic mutations of ALK kinase in neuroblastoma
2008 Nature
Genome-Wide Analysis of Neuroblastomas using High-Density Single Nucleotide Polymorphism Arrays
2007
Chronic Health Conditions in Adult Survivors of Childhood Cancer
2006 Standout
Children's Oncology Group's 2013 blueprint for research: Bone tumors
2012
High‐resolution detection and mapping of genomic DNA alterations in neuroblastoma
2005
Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization
1998
Genome changes and gene expression in human solid tumors
2000
Translation of new cancer treatments from pet dogs to humans
2008 Standout
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
2005 Standout
Bone tumours in European children and adolescents, 1978–1997. Report from the Automated Childhood Cancer Information System project
2006
Oncomirs — microRNAs with a role in cancer
2006 Standout
Recent Advances in Neuroblastoma
2010
Asparaginyl Hydroxylation of the Notch Ankyrin Repeat Domain by Factor Inhibiting Hypoxia-inducible Factor
2007 StandoutNobel
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
2002 Standout
Prediction of clinical outcome and biological characterization of neuroblastoma by expression profiling
2005
Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program
2003
High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma
2000
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
Long-term Complications Following Childhood and Adolescent Cancer: Foundations for Providing Risk-based Health Care for Survivors
2004
Neuroblastoma
2007 Standout
Changes in Incidence and Survival of Ewing Sarcoma Patients Over the Past 3 Decades
2008
The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2
2002
Targeting DNA topoisomerase II in cancer chemotherapy
2009 Standout
Variety and complexity of chromosome 17 translocations in neuroblastoma
2003
Mechanism and relevance of ploidy in neuroblastoma
2000
Ethnic and racial differences in patients with Ewing sarcoma
2010
Genetic parameters of neuroblastomas
2002
Chromosome 1p and 11q Deletions and Outcome in Neuroblastoma
2005
Height at diagnosis and birth-weight as risk factors for osteosarcoma
2011
Trends in incidence of skin basal cell carcinoma. Additional evidence from a UK primary care database study
2007
Treatment of Infections Associated with Surgical Implants
2004 Standout
Neuroblastoma Screening at One Year of Age
2002
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
2016 Standout
Increased incidence of malignancies in Sweden after the Chernobyl accident—a promoting effect?
2006
The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor
2008 StandoutNobel
Genome-wide screen for allelic imbalance in a mouse model for neuroblastoma.
2000
PPM1D is a potential target for 17q gain in neuroblastoma.
2003
Liposomal Muramyl Tripeptide Phosphatidyl Ethanolamine: Ifosfamide-Containing Chemotherapy In Osteosarcoma
2006
Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell line.
2001
Single Center Experience of a New Intensive Induction Therapy for Ewing’s Family of Tumors: Feasibility, Toxicity, and Stem Cell Mobilization Properties
2003
Childhood and adolescent cancer statistics, 2014
2014 Standout
A Systematic Review of Molecular and Biological Tumor Markers in Neuroblastoma
2004
Late Mortality Among 5-Year Survivors of Childhood Cancer: A Summary From the Childhood Cancer Survivor Study
2009
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Childhood Cancer Survival Trends in Europe: A EUROCARE Working Group Study
2005
Biology of Gastrointestinal Stromal Tumors
2004 Standout
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?
2006
Correlation of Early Metastatic Response by123I-Metaiodobenzylguanidine Scintigraphy With Overall Response and Event-Free Survival in Stage IV Neuroblastoma
2003
Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study
2009
[18F]Fluorodeoxyglucose Positron Emission Tomography Predicts Outcome for Ewing Sarcoma Family of Tumors
2005
MYCN Expression Is Not Prognostic of Adverse Outcome in Advanced-Stage Neuroblastoma With Nonamplified MYCN
2000
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma.
2003
A systematic review and evaluation of the use of tumour markers in paediatric oncology: Ewing's sarcoma and neuroblastoma
2003
Molecular Biology of Neuroblastoma
1999
Loss of Heterozygosity at 1p36 Independently Predicts for Disease Progression But Not Decreased Overall Survival Probability in Neuroblastoma Patients: A Children’s Cancer Group Study
2000
Unequivocal Delineation of Clinicogenetic Subgroups and Development of a New Model for Improved Outcome Prediction in Neuroblastoma
2005
Quantitation of marrow disease in neuroblastoma by real-time reverse transcription-PCR.
2001
Osteosarcoma: Current Treatment and a Collaborative Pathway to Success
2015 Standout
A novel and consistent amplicon at 13q31 associated with alveolar rhabdomyosarcoma
2000
Malignant Bone Tumors
2001
Drug Resistance in Cancer: An Overview
2014 Standout
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
2008 Standout
UV Radiation and the Skin
2013 Standout
SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis.
2002
Long-Term Event-Free Survival After Intensive Chemotherapy for Ewing’s Family of Tumors in Children and Young Adults
2003
DNA sequence copy number changes in gastrointestinal stromal tumors: tumor progression and prognostic significance.
2000
Works of Simon Cotterill being referenced
Skin cancer in children and young adults: 28 years' experience from the Northern Region Young Person's Malignant Disease Registry, UK.
2003
True
2000
Gain of Chromosome Arm 17q and Adverse Outcome in Patients with Neuroblastoma
1999
Breakpoint position on 17q identifies the most aggressive neuroblastoma tumors
2002
Clinical prognostic factors in 1277 patients with neuroblastoma: results of The European Neuroblastoma Study Group ‘Survey’ 1982–1992
2000
Cytogenetically cryptic AML1-ETO and CBFbeta-MYH11 gene rearrangements: incidence in 412 cases of acute myeloid leukaemia
2000
High dose melphalan in the treatment of advanced neuroblastoma: Results of a randomised trial (ENSG‐1) by the European Neuroblastoma Study Group
2004
17q gain in neuroblastoma predicts adverse clinical outcome
2001
Stature of young people with malignant bone tumors
2003
Late relapse and prognosis for neuroblastoma patients surviving 5 years or more: A report from the European Neuroblastoma Study Group ?Survey?
2001
Results of the United Kingdom Children's Cancer Study Group first Wilms' Tumor Study.
1995
Incidence and survival for cancer in children and young adults in the North of England, 1968–1995: a report from the Northern Region Young Persons’ Malignant Disease Registry
2000
Thyroid cancer in children and young adults in the North of England. Is increasing incidence related to the Chernobyl accident?
2001
Ifosfamide-containing chemotherapy in Ewing's sarcoma: The Second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study.
1998
Local therapy and other factors influencing site of relapse in patients with localised Ewing's sarcoma
1999
Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patients
1997
Comprehensive Genetic and Histopathologic Study Reveals Three Types of Neuroblastoma Tumors
2001
Skin cancer in children and young adults
2003
Prognostic Factors in Ewing’s Tumor of Bone: Analysis of 975 Patients From the European Intergroup Cooperative Ewing’s Sarcoma Study Group
2000